Angiosarcoma of the ovary treated with polyadenosine ribose polymerase Inhibition, a case report and review of the literature

• Primary angiosarcoma of the ovary historically has no standard treatment due to its rarity, and outcomes have been variable. • Olaparib may represent a viable treatment option for primary angiosarcoma of the ovary with a somatic BRCA mutation. • Next-generation sequencing may play an important com...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Andrea M., Argenta, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481173/
https://www.ncbi.nlm.nih.gov/pubmed/37680504
http://dx.doi.org/10.1016/j.gore.2023.101264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481173/
https://www.ncbi.nlm.nih.gov/pubmed/37680504
http://dx.doi.org/10.1016/j.gore.2023.101264

Ejemplares similares